
Logan Thrasher Collins
@LoganTCollins
Followers
1K
Following
12K
Media
371
Statuses
3K
Futurist, synthetic biologist, author, and inventor. Biotech startup founder. Budding serial biotech entrepreneur. I make science fiction into reality.
St. Louis
Joined July 2017
My recent bioRxiv preprint! We demonstrate an entirely novel way of shielding AAVs from the neutralizing antibodies found in 30-60% of patients - encapsulating the virus inside of an immunologically invisible hollow protein compartment called vault.
10
35
239
Are you a technical founder who wants a better understanding of fundraising in startups? Well, I am too. That's why I wrote up these notes which explore the mechanics and terminology associated with raising rounds. Hope you find this useful as well!.
logancollinsblog.com
PDF version: Notes on Fundraising Mechanics for Startups by Logan Thrasher Collins Valuation A company’s valuation is initially an estimate of how much the company is worth as set by methods such a…
0
0
2
I agree with Alex on everything here. George Church is amazing and this is an unfortunate situation.
George Church is one of my role models. He is super smart, kind, contributed massively to longevity, made numerous breakthroughs, and started many biotech companies. I think that here he fell victim to his enormous generosity and support for the outcasts.
1
1
6
At the @foresightinst AI x Bio conference, I took part in a working group where we suggested something very similar: establish a fund to buy the FDA submission documents from 'dead' biotech companies as a source of AI training data (1/2).
ifp.org
How to fuel AI by unlocking the FDA’s knowledge of biotech failures
1
0
5
RT @daatdarling: We need to re-normalize being an autodidact, you can study things to a high level on your own, and you can continue studyi….
0
111
0
RT @AllenInstitute: Holy Soma Batman!. You never know what you may find when you cruise our MICrONS Explorer, such as a blood vessel pierci….
0
60
0
Great paper which combines expansion microscopy and in situ genome sequencing to map chromatin structure and selected protein targets in cellular nuclei. ExIGS was then used to explore how nuclear lamin protein and genome organization changes during aging.
science.org
Microscopy and genomics are used to characterize cell function, but approaches to connect the two types of information are lacking, particularly at subnuclear resolution. Here, we describe expansion...
0
0
3
Despite the title, this article is hopeful about the future of AAVs. Advances in tech that lowers doses and decreases toxicity may lead to a stronger industry in the end. Most importantly, this will bring lifesaving cures to patients who need them.
biospace.com
In the wake of multiple patient deaths from liver injuries related to Sarepta Therapeutics’ AAV gene therapy platform, some in the sector are looking for ways to improve the current technology, while...
0
0
2